65 filings
Page 3 of 4
8-K
188h1z7
7 Nov 19
Jounce Therapeutics Reports Third Quarter 2019 Financial Results
6:43am
8-K
xfxpge88kd94k5h9g
4 Sep 19
Regulation FD Disclosure
8:51am
8-K
yv34l9d yf
7 Aug 19
Jounce Therapeutics Reports Second Quarter 2019 Financial Results
7:16am
8-K
skxkqoi1q06r18hwfu
23 Jul 19
Entry into a Material Definitive Agreement
4:05pm
8-K
b9rfusfl cfv
13 Jun 19
Submission of Matters to a Vote of Security Holders
10:27am
8-K
o2l364i9
8 May 19
Jounce Therapeutics Reports First Quarter 2019 Financial Results
7:12am
8-K
m9zhzpc
6 Mar 19
Jounce Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results
7:19am
8-K
x1z0u
7 Jan 19
Results of Operations and Financial Condition
8:04am
8-K
3z64q
13 Nov 18
Jounce Therapeutics Reports Third Quarter 2018 Financial Results
7:06am
8-K
9j4yr777
9 Nov 18
Regulation FD Disclosure
8:07am
8-K
af20wndv0pmpnjqua71
9 Aug 18
Jounce Therapeutics Reports Second Quarter 2018 Financial Results
7:20am
8-K
zzdqlp0
22 Jun 18
Submission of Matters to a Vote of Security Holders
4:49pm
8-K
p0wsev
5 Jun 18
Regulation FD Disclosure
12:00am
8-K
28yqbzqv8bvyo
4 Jun 18
Jounce Therapeutics Presents Preliminary Efficacy Data from Ongoing Phase 1/2 ICONIC Trial of JTX-2011 in Patients with Advanced Cancers
12:00am
8-K
9ts3l
9 May 18
Jounce Therapeutics Reports First Quarter 2018 Financial Results
7:25am
8-K
mvn515hd1
8 Mar 18
Jounce Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results
12:00am
8-K
rvjgu9l
8 Jan 18
Results of Operations and Financial Condition
12:00am
8-K
b2m osszh8q
13 Nov 17
Jounce Therapeutics Reports Third Quarter 2017 Financial Results
12:00am
8-K
29jez 59e0
23 Oct 17
Departure of Directors or Certain Officers
12:00am
8-K
ssnuz4
9 Aug 17
Jounce Therapeutics Reports Second Quarter 2017 Financial Results
12:00am